Equity impact of HPV vaccination on lifetime projections of cervical cancer burden among cohorts in 84 countries by global, regional, and income levels, 2010–22: a modelling study
Open Access
- 11 March 2024
- journal article
- research article
- Published by Elsevier in eClinicalMedicine
- Vol. 70, 102524
Abstract
No abstract availableKeywords
Funding Information
- Japan Agency for Medical Research and Development (JP223fa627004)
- UK Research and Innovation
- Bill and Melinda Gates Foundation (INV-034281)
- Wellcome Trust
- World Health Organization
- Centers for Disease Control and Prevention
- National Institute for Health and Care Research
This publication has 23 references indexed in Scilit:
- HPV vaccination introduction worldwide and WHO and UNICEF estimates of national HPV immunization coverage 2010–2019Preventive Medicine, 2021
- Estimating the health impact of vaccination against ten pathogens in 98 low-income and middle-income countries from 2000 to 2030: a modelling studyThe Lancet, 2021
- Human papillomavirus vaccines: WHO position paper, May 2017–RecommendationsVaccine, 2017
- Human papillomavirus vaccines: WHO position paper, October 2014—RecommendationsVaccine, 2015
- Overcoming barriers to HPV vaccination: Non-inferiority of antibody response to human papillomavirus 16/18 vaccine in adolescents vaccinated with a two-dose vs. a three-dose schedule at 21 monthsVaccine, 2014
- Immunogenicity of 2 Doses of HPV Vaccine in Younger Adolescents vs 3 Doses in Young WomenJAMA, 2013
- A Review of Clinical Trials of Human Papillomavirus Prophylactic VaccinesVaccine, 2012
- Human papillomavirus type distribution in 30,848 invasive cervical cancers worldwide: Variation by geographical region, histological type and year of publicationInternational Journal of Cancer, 2010
- WHO position on HPV vaccinesVaccine, 2009
- On the measurement of inequalities in healthSocial Science & Medicine, 1991